Insider Selling News: Keryx Biopharmaceuticals (KERX), Facebook Inc (FB), Celgene Corporation (CELG), Illumina, Inc. (ILMN)


Recently, various executives have taken part in insider selling activity for the stocks of Keryx Biopharmaceuticals (NASDAQ:KERX), Facebook Inc (NASDAQ:FB), Celgene Corporation (NASDAQ:CELG), and Illumina, Inc. (NASDAQ:ILMN).

Keryx Biopharmaceuticals

President and CEO Greg Madison sold 1,683 Keryx shares (1.55% of total stake), valued at $10,216, in a transaction dated August 10. Madison now holds 106,735 of the company’s shares that are valued at $659,622. According to TipRanks.com, which measures corporate insiders’ success based on their transactions, Greg Madison has an average return of 30.5% and a 66.7% success rate. Madison is ranked #6717 out of 33460 corporate insiders.

Click Here to see the performance of Keryx Biopharmaceuticals insiders.

Facebook Inc

VP Gen Counsel and Secretary Colin Stretch unloaded 1,000 Facebook shares (1.32% of total stake), valued at $93,750, on August 11. The shares were sold via automatic sale program. Stretch now holds 74,512 of the company’s shares that are valued at $7,007,854. Colin Stretch has an average return of 26.1% and a 100% success rate, according to TipRanks. Stretch is ranked #4712 out of 33460 corporate insiders.

Click Here to see the performance of Facebook insiders.

Celgene Corporation

President, Global Research and Early Development Thomas Daniel disposed of 25,578 Celgene shares (28.12% of total stake), valued at $3,346,114, in a transaction dated August 10. The shares were sold via automatic sale program. Daniel now holds directly and indirectly 65,378 of the company’s shares that are valued at $8,593,938. Thomas Daniel has an average return of -15.9% and a 50% success rate. Daniel is ranked #21294 out of 33460 corporate insiders.

Click Here to see the performance of Celgene insiders.

Illumina, Inc.

Director Robert S. Epstein unloaded 2,000 Illumina (20.13% of total stake), valued at $424,180, on August 10. The shares were sold via automatic sale program. Epstein now holds 7,935 of the company’s shares that are valued at $1,648,179.

Director David Walt sold 5,497 shares valued at $1,147,168, in four transactions dated August 11. The shares were sold via automatic sale program. Walt now holds directly and indirectly 695,800 of the company’s shares that are valued at $144,524,618.

Click Here to see the performance of Illumina insiders.